434 related articles for article (PubMed ID: 23132858)
1. Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.
Li J; Kanekiyo T; Shinohara M; Zhang Y; LaDu MJ; Xu H; Bu G
J Biol Chem; 2012 Dec; 287(53):44593-601. PubMed ID: 23132858
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.
Lee CY; Tse W; Smith JD; Landreth GE
J Biol Chem; 2012 Jan; 287(3):2032-44. PubMed ID: 22130662
[TBL] [Abstract][Full Text] [Related]
3. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.
Furusawa K; Takasugi T; Chiu YW; Hori Y; Tomita T; Fukuda M; Hisanaga SI
J Biol Chem; 2019 Jul; 294(28):10886-10899. PubMed ID: 31138646
[TBL] [Abstract][Full Text] [Related]
4. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
5. The endocytic pathway taken by cationic substances requires Rab14 but not Rab5 and Rab7.
Trofimenko E; Homma Y; Fukuda M; Widmann C
Cell Rep; 2021 Nov; 37(5):109945. PubMed ID: 34731620
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
[TBL] [Abstract][Full Text] [Related]
8. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
Belinson H; Lev D; Masliah E; Michaelson DM
J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
[TBL] [Abstract][Full Text] [Related]
9. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases.
Dale LB; Seachrist JL; Babwah AV; Ferguson SS
J Biol Chem; 2004 Mar; 279(13):13110-8. PubMed ID: 14711821
[TBL] [Abstract][Full Text] [Related]
11. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
12. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
Prasad H; Rao R
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
[TBL] [Abstract][Full Text] [Related]
13. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
16. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
17. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of β-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons.
Song MS; Baker GB; Todd KG; Kar S
Neuroscience; 2011 Mar; 178():181-8. PubMed ID: 21262324
[TBL] [Abstract][Full Text] [Related]
19. A flow cytometry-based
Kara E; Marks JD; Roe AD; Commins C; Fan Z; Calvo-Rodriguez M; Wegmann S; Hudry E; Hyman BT
J Biol Chem; 2018 Aug; 293(34):13247-13256. PubMed ID: 29950521
[TBL] [Abstract][Full Text] [Related]
20. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
